Indaptus Therapeutics Inc (NASDAQ:INDP) Over 25% of INDP's tradable shares are in the hands of short sellers, meaning they sold the stock and are holding for further declines. Unlike buying a stock, when you can only lose as much as you invest, a short seller's loss potential is unlimited, which is one of the reasons why short squeezes occur, specifically in stocks like INDP with a thin public float. Chief Executive Officer, will participate in a pre-recorded presentation at the H.C. Wainwright BioConnect 2022 Virtual Conference made available on Monday, so stay tuned. The stock has built a nice base, which suggests the shares could keep moving significantly higher in the coming months. Definitely on watch next week.